Refreshing results…
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
UploadRTK Inhibitors in Melanoma: From Bench to Bedside
Download from doi.orgMissing publications? Search for publications with a matching author name.